2,1,3-苯并噻唑-5-胺
|
B195481-5g
|
≥97% |
874-37-3 |
5g
|
¥ 479.9
|
现货 |
阿拉丁 |
2,1,3-苯并噻唑-5-胺
|
B195481-25g
|
≥97% |
874-37-3 |
25g
|
¥ 2387.9
|
现货 |
阿拉丁 |
PDEC-NB
|
P412473-500mg
|
≥98% |
874302-76-8 |
500mg
|
¥ 3355.9
|
现货 |
阿拉丁 |
PDEC-NB
|
P412473-25mg
|
≥98% |
874302-76-8 |
25mg
|
¥ 462.9
|
现货 |
阿拉丁 |
顺-2-氨基环戊烷甲腈
|
C346599-500mg
|
≥96% |
874293-75-1 |
500mg
|
¥ 7209.9
|
期货,请咨询 |
阿拉丁 |
顺-2-氨基环戊烷甲腈
|
C346599-25mg
|
≥96% |
874293-75-1 |
25mg
|
¥ 720.9
|
期货,请咨询 |
阿拉丁 |
(S)-(-)-四氢呋喃-2-羧酸
|
S161338-100g
|
≥98%(GC) |
87392-07-2 |
100g
|
¥ 726.9
|
现货 |
阿拉丁 |
Ro 3306,细胞周期蛋白依赖性激酶(Cdk1)抑制剂
|
R275210-25mg
|
Moligand™, ≥98% |
872573-93-8 |
25mg
|
¥ 1324.9
|
现货 |
阿拉丁 |
依美斯汀
|
E413308-100mg
|
Moligand™, ≥97% |
87233-61-2 |
100mg
|
¥ 5370.9
|
期货,请咨询 |
阿拉丁 |
D-蛋氨醇
|
D339853-250mg
|
≥95% |
87206-44-8 |
250mg
|
¥ 277.9
|
现货 |
阿拉丁 |
9-己基-2,7-双(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)-9H-咔唑
|
H290881-5g
|
≥99% |
871696-12-7 |
5g
|
¥ 329.9
|
现货 |
阿拉丁 |
9-己基-2,7-双(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)-9H-咔唑
|
H290881-250mg
|
≥99% |
871696-12-7 |
250mg
|
¥ 27.9
|
现货 |
阿拉丁 |
SC-66
|
S276006-5mg
|
≥99% |
871361-88-5 |
5mg
|
¥ 118.9
|
现货 |
阿拉丁 |
SC-66
|
S276006-25mg
|
≥99% |
871361-88-5 |
25mg
|
¥ 238.9
|
现货 |
阿拉丁 |
SC-66
|
S276006-100mg
|
≥99% |
871361-88-5 |
100mg
|
¥ 484.9
|
现货 |
阿拉丁 |
雷特格韦钾盐
|
R304804-500mg
|
≥97% |
871038-72-1 |
500mg
|
¥ 4633.9
|
现货 |
阿拉丁 |
雷特格韦钾盐
|
R304804-1g
|
≥97% |
871038-72-1 |
1g
|
¥ 7414.9
|
现货 |
阿拉丁 |
TAK-285
|
T126234-25mg
|
≥98% |
871026-44-7 |
25mg
|
¥ 4077.9
|
现货 |
阿拉丁 |
2,4-二氟-3-甲酰基苯基硼酸 (含有不定量的酸酐)
|
D340890-5g
|
≥95% |
870718-06-2 |
5g
|
¥ 863.9
|
期货,请咨询 |
阿拉丁 |
2,4-二氟-3-甲酰基苯基硼酸 (含有不定量的酸酐)
|
D340890-25g
|
≥95% |
870718-06-2 |
25g
|
¥ 2937.9
|
现货 |
阿拉丁 |
2,4-二氟-3-甲酰基苯基硼酸 (含有不定量的酸酐)
|
D340890-250mg
|
≥95% |
870718-06-2 |
250mg
|
¥ 98.9
|
现货 |
阿拉丁 |
R-1-Cbz-3-氨基吡咯烷盐酸盐
|
C121656-25g
|
≥98% |
870621-17-3 |
25g
|
¥ 1408.9
|
现货 |
阿拉丁 |
2-吗啉基嘧啶-5-基硼酸(含不同量的酸酐)
|
M187287-5g
|
≥98% |
870521-33-8 |
5g
|
¥ 497.9
|
期货,请咨询 |
阿拉丁 |
PF-00835231
|
P414478-50mg
|
Moligand™, ≥98% |
870153-29-0 |
50mg
|
¥ 8239.9
|
现货 |
阿拉丁 |